InceptionR’s CONMED CNMD Stock Holding History

InceptionR’s Portfolio CNMD Stock Details CNMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-3,106	Closed	-$213K	–	589
2024 Q4	$213K	Buy	3,106 +43	+1%	+$3K	0.05%	547
2024 Q3	$220K	Buy	+3,063	New	+$216K	0.05%	549
2024 Q2	–	Sell	-2,844	Closed	-$228K	–	628
2024 Q1	$228K	Sell	2,844 -783	-22%	-$69.8K	0.06%	491
2023 Q4	$397K	Buy	3,627 +246	+7%	+$25.4K	0.28%	147
2023 Q3	$341K	Buy	3,381 +1,839	+119%	+$211K	0.19%	230
2023 Q2	$210K	Buy	+1,542	New	+$188K	0.11%	367

Other funds holding CNMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

WHG

Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

SAM

Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return

InceptionR's CNMD Position: Q1 2025 in Review

InceptionR sold out of CONMED (CNMD) in Q1 2025, closing a stake of 3,106 shares — an estimated $213K sold.

InceptionR first reported a position in CNMD in Q2 2023 and held it in 6 quarters. The position peaked at $397K in Q4 2023. 280 funds tracked by Wall St. Rank hold CNMD as of Q1 2025.

InceptionR reported no remaining CONMED position as of Q1 2025 after selling out during the quarter.
InceptionR sold 3,106 CONMED shares in Q1 2025, an estimated $213K.
InceptionR first reported a position in CONMED in Q2 2023 and held it in 6 quarters.
InceptionR's CONMED position peaked at $397K in Q4 2023.
280 funds tracked by Wall St. Rank held CONMED as of Q1 2025.

Based on InceptionR's 13F filing for Q1 2025, filed 12 May 2025.